We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Procedure Kit Simplifies Endovenous Laser Treatment

By HospiMedica International staff writers
Posted on 29 Mar 2012
A new procedure kit for endovenous laser treatment (EVLT) helps reduce procedure steps in the treatment of varicose veins. More...


The NeverTouch Direct procedure kit is used in endovascular coagulation of the great saphenous vein (GSV) for patients with superficial vein reflux, for the treatment of varicose veins and varicosities associated with superficial reflux of the GSV, and for the treatment of incompetence and reflux of superficial veins of the lower extremity. The new kit simplifies the EVLT procedure by eliminating the need for a long guide wire or guiding sheath, thus reducing patient pain levels and causing less bruising when compared to bare-tip fibers.

The procedure kit is available in 25 cm, 45 cm, 65 cm, and 90 cm, and also is available with an .018” access system, which eliminates the need for a 5F micro-access sheath and does away with the need to subsequently exchange wires and size up, resulting in fewer procedure steps and a faster procedure time. The device is intended for use with the VenaCure EVLT ablation system. Both the NeverTouch Direct and the the VenaCure EVLT ablation system are products of AngioDynamics (Latham, NY, USA), and have been approved by the US Food and Drug Administration (FDA).

“NeverTouch Direct and the sheathless fiber option further expands the physician's ability to tailor treatment to each individual patient, and avoid one-size-fits-all approaches that limit the physician's ability to exercise their clinical judgment,” said Alan Panzer, Senior Vice President and General Manager of AngioDynamics.

EVLT involves the insertion of a catheter bearing a laser fiber into the GSV or small saphenous vein (SSV) through a small puncture. The catheter is then advanced under ultrasound guidance to the level of the groin or knee crease. The laser is activated while the catheter or laser fiber is slowly withdrawn, resulting in obliteration of the saphenous vein along its entire length. The treatment, which is performed without sedation, usually takes 1-2 hours and the patient walks out under his or her own power. Foam sclerotherapy or ambulatory phlebectomy is often performed at the time of the procedure or within the first 1–2 weeks to treat branch varicose veins.

Related Links:
AngioDynamics


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
New
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.